MedTrace Logo

Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle

NCT04842851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2021-04-13

No results posted yet for this study

Summary

This study aims to analyze outcomes of patients with systemic right ventricle (SRV) implanted with Cardiac Resynchronization Therapy (CRT) systems and to compare the impact of CRT in SRV patients with other congenital heart diseases (CHD).

Conditions

  • Congenital Heart Disease

Interventions

DEVICE

cardiac resynchronization therapy

Cardiac resynchronization therapy in patients with systemic right ventricle

Sponsors & Collaborators

  • Marie Lannelongue Hospital, Le Plessis Robinson, France

    collaborator UNKNOWN

  • Clinique Pasteur Toulouse

    collaborator OTHER

  • Groupe Hospitalier Pitie-Salpetriere

    collaborator OTHER

  • Hopital Louis Pradel

    collaborator OTHER

  • University Hospital, Montpellier

    collaborator OTHER

  • European Georges Pompidou Hospital

    collaborator OTHER

  • Paris Cardiovascular Research Center (Inserm U970)

    lead OTHER_GOV

Principal Investigators

  • Victor Waldmann, MD, PhD · Georges Pompidou European Hospital, Paris, France

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-01
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04842851 on ClinicalTrials.gov